Global and China Precision Medicine Dynamic Monitoring and Future Investment Report

Global and China Precision Medicine Dynamic Monitoring and Future Investment Report 2023

Global and China Precision Medicine Dynamic Monitoring and Future Investment Report

Global and China Precision Medicine Dynamic Monitoring and Future Investment Report 2023


Insights into the Market include supply chain optimization, last-mile delivery challenges, and growth forecasts segmented by region and service type.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The report aims at estimating the market size and future growth potential of Precision Medicine market across different segments such as type, application and geography. The base year considered for the study is 2022, and the market size is forecast from 2023 to 2029.

The global Precision Medicine market size in 2022 is 7330.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 12.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Precision Medicine market include Moderna, Inc. (U.S.), Personalis, Inc. (U.S.), CureVac SE (Germany), Celldex Therapeutics (U.S.), and BioNTech SE (Germany). The share of the top 3 players in the Precision Medicine market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Precision Medicine market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Pharmacogenomics accounted for XX% of Precision Medicine market in 2022. Point-of-Care Testing share of XX%.

Diagnostics accounted for XX% of the Precision Medicine market in 2022. Therapeutics accounts for XX%.

The research methodology used to estimate and forecast the Precision Medicine market begins by capturing data on key market player revenues through secondary research. The bottom-up procedure has been employed to arrive at the overall market size, by considering the revenue of key players in the market. After arriving at the overall market size, the total market has been split into several segments and sub-segments, which has been verified through primary research by conducting extensive interviews with key people such as industry experts, executives. This data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for segments and sub-segments.

This report provides the integrated ecosystem of the Precision Medicine market which offers holistic view of current demand and vendor side market. The research study answers several significant questions, primarily which market segments to focus on in next two to five years to prioritize factors such as resource effort, and investment.

Key Target audience:

Precision Medicine Manufacturers and Suppliers

Research and Development (R&D) Companies

Business Research and Consulting Service Providers

Research Organizations

Academic Centers and Universities Associations and Industrial Bodies

Technology Investors

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Market Data Breakdown by Regions

North America

United States

Canada

China

Asia Pacific (Excluding China)

Japan

Korea

Southeast Asia

India

Australia

EMEA

Europe

Germany

France

UK

Italy

Russia

Nordic

Middle East

Africa

Latin America

Brazil

Argentina

Mexico

Some prominent players in the market includes:

Moderna, Inc. (U.S.)

Personalis, Inc. (U.S.)

CureVac SE (Germany)

Celldex Therapeutics (U.S.)

BioNTech SE (Germany)

Advaxis, Inc. (U.S.)

Agenus Inc. (U.S.)

Immatics Biotechnologies GmbH (Germany)

Gritstone Oncology (U.S.)

ImmunityBio, Inc. (U.S.)

bioMérieux SA (France)

Bayer AG (Germany)

Pfizer Inc. (U.S.)

GSK plc (U.K.)

F. Hoffmann-La Roche Ltd. (Switzerland)

Market Data Breakdown by Type

Pharmacogenomics

Point-of-Care Testing

Stem Cell Therapy

Pharmacoproteomics

Others

Market Data Breakdown by Applications

Diagnostics

Therapeutics

Others

Table of Content

1 Precision Medicine Market Introduction and Overview

1.1 Precision Medicine Definition

1.2 Research Purposes

1.3 Currency Rate

1.4 Report Timeline

1.5 Economic Analysis of Global Regions

1.6 Inflation Analysis

2 Precision Medicine Business Cost Analysis

2.1 Proportion of Manufacturing Cost Structure

2.1.1 Labor Cost

2.1.2 Operating Expenses

2.2 Precision Medicine Industrial Chain Analysis

3 Market Competition by Manufacturers

3.1 Global Precision Medicine Revenue and Market Share by Manufacturer

3.2 Manufacturers Precision Medicine Production Sites, Area Served, Product Types

3.3 Precision Medicine Market Competitive Situation and Trends

3.3.1 Precision Medicine Market Concentration Rate

3.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023

3.3.3 Mergers & Acquisitions, Expansion

4 Players Profiles

4.1 Moderna, Inc. (U.S.)

4.1.1 Moderna, Inc. (U.S.) Company Profile

4.1.2 Precision Medicine Product Overview

4.1.3 Moderna, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

4.1.4 Moderna, Inc. (U.S.) Business Overview

4.2 Personalis, Inc. (U.S.)

4.2.1 Personalis, Inc. (U.S.) Company Profile

4.2.2 Precision Medicine Product Overview

4.2.3 Personalis, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

4.2.4 Personalis, Inc. (U.S.) Business Overview

4.3 CureVac SE (Germany)

4.3.1 CureVac SE (Germany) Company Profile

4.3.2 Precision Medicine Product Overview

4.3.3 CureVac SE (Germany) Precision Medicine Market Performance (2018-2023)

4.3.4 CureVac SE (Germany) Business Overview

4.4 Celldex Therapeutics (U.S.)

4.4.1 Celldex Therapeutics (U.S.) Company Profile

4.4.2 Precision Medicine Product Overview

4.4.3 Celldex Therapeutics (U.S.) Precision Medicine Market Performance (2018-2023)

4.4.4 Celldex Therapeutics (U.S.) Business Overview

4.5 BioNTech SE (Germany)

4.5.1 BioNTech SE (Germany) Company Profile

4.5.2 Precision Medicine Product Overview

4.5.3 BioNTech SE (Germany) Precision Medicine Market Performance (2018-2023)

4.5.4 BioNTech SE (Germany) Business Overview

4.6 Advaxis, Inc. (U.S.)

4.6.1 Advaxis, Inc. (U.S.) Company Profile

4.6.2 Precision Medicine Product Overview

4.6.3 Advaxis, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

4.6.4 Advaxis, Inc. (U.S.) Business Overview

4.7 Agenus Inc. (U.S.)

4.7.1 Agenus Inc. (U.S.) Company Profile

4.7.2 Precision Medicine Product Overview

4.7.3 Agenus Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

4.7.4 Agenus Inc. (U.S.) Business Overview

4.8 Immatics Biotechnologies GmbH (Germany)

4.8.1 Immatics Biotechnologies GmbH (Germany) Company Profile

4.8.2 Precision Medicine Product Overview

4.8.3 Immatics Biotechnologies GmbH (Germany) Precision Medicine Market Performance (2018-2023)

4.8.4 Immatics Biotechnologies GmbH (Germany) Business Overview

4.9 Gritstone Oncology (U.S.)

4.9.1 Gritstone Oncology (U.S.) Company Profile

4.9.2 Precision Medicine Product Overview

4.9.3 Gritstone Oncology (U.S.) Precision Medicine Market Performance (2018-2023)

4.9.4 Gritstone Oncology (U.S.) Business Overview

4.10 ImmunityBio, Inc. (U.S.)

4.10.1 ImmunityBio, Inc. (U.S.) Company Profile

4.10.2 Precision Medicine Product Overview

4.10.3 ImmunityBio, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

4.10.4 ImmunityBio, Inc. (U.S.) Business Overview

4.11 bioMérieux SA (France)

4.11.1 bioMérieux SA (France) Company Profile

4.11.2 Precision Medicine Product Overview

4.11.3 bioMérieux SA (France) Precision Medicine Market Performance (2018-2023)

4.11.4 bioMérieux SA (France) Business Overview

4.12 Bayer AG (Germany)

4.12.1 Bayer AG (Germany) Company Profile

4.12.2 Precision Medicine Product Overview

4.12.3 Bayer AG (Germany) Precision Medicine Market Performance (2018-2023)

4.12.4 Bayer AG (Germany) Business Overview

4.13 Pfizer Inc. (U.S.)

4.13.1 Pfizer Inc. (U.S.) Company Profile

4.13.2 Precision Medicine Product Overview

4.13.3 Pfizer Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

4.13.4 Pfizer Inc. (U.S.) Business Overview

4.14 GSK plc (U.K.)

4.14.1 GSK plc (U.K.) Company Profile

4.14.2 Precision Medicine Product Overview

4.14.3 GSK plc (U.K.) Precision Medicine Market Performance (2018-2023)

4.14.4 GSK plc (U.K.) Business Overview

4.15 F. Hoffmann-La Roche Ltd. (Switzerland)

4.15.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile

4.15.2 Precision Medicine Product Overview

4.15.3 F. Hoffmann-La Roche Ltd. (Switzerland) Precision Medicine Market Performance (2018-2023)

4.15.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview

5 Global Precision Medicine Historical and Forecast Market Analysis by Type

5.1 Market Size Analysis by Types

5.2 Global Precision Medicine Revenue and Market Share by Type

5.3 Global Precision Medicine Revenue Market Forecast by Type (2023-2029)

6 Global Precision Medicine Historical and Forecast Market Analysis by Application

6.1 Market Size Analysis by Application

6.2 Global Precision Medicine Revenue Market Share by Application (2018-2023)

6.3 Precision Medicine Revenue Market Forecast by Application (2023-2029)

7 Global Market Growth Trends Analysis

7.1 Global Precision Medicine Market Size & Forecast (2018-2029)

7.2 Precision Medicine Growth Trends Analysis by Regions

7.2.1 Precision Medicine Market Size by Regions: 2018 VS 2023 VS 2029

7.2.2 Precision Medicine Historic Revenue Market Size by Regions (2018-2023)

7.2.3 Precision Medicine Forecasted Revenue Market Size by Regions (2023-2029)

7.2.4 North America Precision Medicine Market Size & Forecast (2018-2029)

7.2.5 EMEA Precision Medicine Market Size & Forecast (2018-2029)

7.2.6 China Precision Medicine Market Size & Forecast (2018-2029)

7.2.7 Asia-Pacific (Excluding China) Precision Medicine Market Size & Forecast (2018-2029)

7.2.8 Latin America Precision Medicine Market Size & Forecast (2018-2029)

8 North America

8.1 North America Precision Medicine Revenue by Players

8.2 North America Precision Medicine Revenue by Types

8.3 North America Precision Medicine Revenue by Applications

8.4 North America Precision Medicine Market by Countries

8.4.1 North America Precision Medicine Revenue by Countries (2018-2029)

8.5 North America SWOT Analysis

8.6 United States

8.7 Canada

9 China

9.1 China Precision Medicine Revenue by Players

9.2 China Precision Medicine Revenue by Types

9.3 China Precision Medicine Revenue by Applications

9.4 China SWOT Analysis

9.5 China

10 Asia Pacific (Excluding China)

10.1 Asia Pacific Precision Medicine Revenue by Players

10.2 Asia Pacific Precision Medicine Revenue by Types

10.3 Asia Pacific Precision Medicine Revenue by Applications

10.4 Asia Pacific Precision Medicine Market by Countries

10.4.1 Asia Pacific Precision Medicine Revenue by Countries (2018-2029)

10.5 Asia Pacific SWOT Analysis

10.6 Japan

10.7 Korea

10.8 Southeast Asia

10.9 India

10.10 Australia

11 EMEA

11.1 EMEA Precision Medicine Revenue by Players

11.2 EMEA Precision Medicine Revenue by Types

11.3 EMEA Precision Medicine Revenue by Applications

11.4 EMEA Precision Medicine Market by Countries

11.4.1 EMEA Precision Medicine Revenue by Countries (2018-2029)

11.5 EMEA SWOT Analysis

11.6 Europe

11.6.1 Europe Precision Medicine Revenue by Countries (2018-2029)

11.6.2 Germany

11.6.3 France

11.6.4 UK

11.6.5 Italy

11.6.6 Russia

11.6.7 Nordic

11.7 Middle East

11.8 Africa

12 Latin America

12.1 Latin America Precision Medicine Revenue by Players

12.2 Latin America Precision Medicine Revenue by Types

12.3 Latin America Precision Medicine Revenue by Applications

12.4 Latin America Precision Medicine Market by Countries

12.4.1 Latin America Precision Medicine Revenue by Countries (2018-2029)

12.5 Latin America SWOT Analysis

12.6 Brazil

12.7 Argentina

12.8 Mexico

13 Precision Medicine Industry Dynamic Analysis

13.1 Precision Medicine Market Trends Analysis

13.2 Precision Medicine Market Drivers Analysis

13.3 Precision Medicine Market Challenges Analysis

13.4 Precision Medicine Market Restraints Analysis

14 Research Findings and Conclusion

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Global and China Precision Medicine Dynamic Monitoring and Future Investment Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What trends are influencing the growth of the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market?
New players are entering the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What is the expected rate of growth in the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market?
From 2025 to 2030, the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
Is further segmentation possible given the scope of the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market study?
Yes, the add-on segmentation is available in the premium customised version of the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
What are the top priorities for the growth of the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market?
In this highly competitive and rapidly evolving Global and China Precision Medicine Dynamic Monitoring and Future Investment Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.